OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma
Wenying Shu, Xue Zhu, Ke Wang, et al.
Cellular Oncology (2022) Vol. 45, Iss. 4, pp. 601-619
Open Access | Times Cited: 7
Wenying Shu, Xue Zhu, Ke Wang, et al.
Cellular Oncology (2022) Vol. 45, Iss. 4, pp. 601-619
Open Access | Times Cited: 7
Showing 7 citing articles:
Erdafitinib promotes ferroptosis in human uveal melanoma by inducing ferritinophagy and lysosome biogenesis via modulating the FGFR1/mTORC1/TFEB signaling axis
Xue Zhu, Ling Wang, Ke Wang, et al.
Free Radical Biology and Medicine (2024) Vol. 222, pp. 552-568
Closed Access | Times Cited: 3
Xue Zhu, Ling Wang, Ke Wang, et al.
Free Radical Biology and Medicine (2024) Vol. 222, pp. 552-568
Closed Access | Times Cited: 3
ITGB2-ICAM1 axis promotes liver metastasis in BAP1-mutated uveal melanoma with retained hypoxia and ECM signatures
Jiaoduan Li, Dongyan Cao, Lixin Jiang, et al.
Cellular Oncology (2023) Vol. 47, Iss. 3, pp. 951-965
Closed Access | Times Cited: 8
Jiaoduan Li, Dongyan Cao, Lixin Jiang, et al.
Cellular Oncology (2023) Vol. 47, Iss. 3, pp. 951-965
Closed Access | Times Cited: 8
SOAT1 in gallbladder cancer: Clinicopathological significance and avasimibe therapeutics
Yuqun Hong, Xiahenazi Abudukeremu, Feifei She, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 6
Closed Access | Times Cited: 2
Yuqun Hong, Xiahenazi Abudukeremu, Feifei She, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 6
Closed Access | Times Cited: 2
Machine learning-based identification of an immunotherapy-related signature to enhance outcomes and immunotherapy responses in melanoma
Zaidong Deng, Jie Liu, Yanxun V. Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Zaidong Deng, Jie Liu, Yanxun V. Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Myosin light chain kinase-mediated epithelial barrier dysfunction as a potential pathogenic mechanism of afatinib-induced diarrheas: A study in human colonoid model
Nichakorn Worakajit, Saravut Satitsri, Taya Kitiyakara, et al.
European Journal of Pharmacology (2024), pp. 177174-177174
Closed Access
Nichakorn Worakajit, Saravut Satitsri, Taya Kitiyakara, et al.
European Journal of Pharmacology (2024), pp. 177174-177174
Closed Access
Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells
Wenying Shu, Janney Z. Wang, Xue Zhu, et al.
Journal of Cancer (2023) Vol. 14, Iss. 18, pp. 3477-3495
Open Access | Times Cited: 1
Wenying Shu, Janney Z. Wang, Xue Zhu, et al.
Journal of Cancer (2023) Vol. 14, Iss. 18, pp. 3477-3495
Open Access | Times Cited: 1
Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells
Wenying Shu, Janney Z. Wang, Xue Zhu, et al.
Research Square (Research Square) (2022)
Closed Access
Wenying Shu, Janney Z. Wang, Xue Zhu, et al.
Research Square (Research Square) (2022)
Closed Access
